Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica
Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associa...
Saved in:
Published in | Respiratory research Vol. 17; no. 1; p. 160 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
28.11.2016
BioMed Central Ltd Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1465-993X 1465-9921 1465-993X |
DOI | 10.1186/s12931-016-0478-5 |
Cover
Abstract | Background
Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling.
Methods
C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology.
Results
Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated.
Conclusions
We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. |
---|---|
AbstractList | Background
Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling.
Methods
C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology.
Results
Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated.
Conclusions
We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. Methods C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Results Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. Conclusions We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-[alpha] and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling.BACKGROUNDOccupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling.C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology.METHODSC57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology.Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated.RESULTSMice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated.We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling.CONCLUSIONSWe characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-α and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive fibrosis. A substantial number of patients diagnosed with silicosis develop pulmonary hypertension. Pulmonary hypertension associated with silicosis and with related restrictive lung diseases significantly reduces survival in affected subjects. An animal model of silicosis has been described previously however, the magnitude of vascular remodeling and hemodynamic effects of inhaled silica are largely unknown. Considering the importance of such information, this study investigated whether mice exposed to silica develop pulmonary hypertension and vascular remodeling. Methods C57BL6 mice were intratracheally injected with either saline or crystalline silica at doses 0.2 g/kg, 0.3 g/kg and 0.4 g/kg and then studied at day 28 post-exposure. Pulmonary hypertension was characterized by changes in right ventricular systolic pressure and lung histopathology. Results Mice exposed to saline showed normal lung histology and hemodynamic parameters while mice exposed to silica showed increased right ventricular systolic pressure and marked lung pathology characterized by a granulomatous inflammatory reaction and increased collagen deposition. Silica-exposed mice also showed signs of vascular remodeling with pulmonary artery muscularization, vascular occlusion, and medial thickening. The expression of pro-inflammatory genes such as TNF-[alpha] and MCP-1 was significantly upregulated as well as the expression of the pro-remodeling genes collagen type I, fibronectin and the metalloproteinases MMP-2 and TIMP-1. On the other hand, the expression of several vasculature specific genes involved in the regulation of endothelial function was significantly attenuated. Conclusions We characterized a new animal model of pulmonary hypertension secondary to pulmonary fibrosis induced by crystalline silica. Our data suggest that silica promotes the damage of the pulmonary vasculature through mechanisms that might involve endothelial dysfunction, inflammation, and vascular remodeling. Keywords: Silicosis, Pulmonary hypertension, Vascular remodeling, Animal model |
ArticleNumber | 160 |
Audience | Academic |
Author | Zelko, Igor N. Ritzenthaler, Jeffrey D. Zhu, Jianxin Roman, Jesse |
Author_xml | – sequence: 1 givenname: Igor N. surname: Zelko fullname: Zelko, Igor N. email: igor.zelko@louisville.edu organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville, Department of Biochemisry and Molecular Genetics, University of Louisville – sequence: 2 givenname: Jianxin surname: Zhu fullname: Zhu, Jianxin organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville – sequence: 3 givenname: Jeffrey D. surname: Ritzenthaler fullname: Ritzenthaler, Jeffrey D. organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville – sequence: 4 givenname: Jesse surname: Roman fullname: Roman, Jesse organization: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Louisville, Robley Rex VA Medical Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27894297$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1rFTEUhoNU7If-ADcScONmaj4nyUYoxS8o6KKCuxAzZ25TMsk1mSm9_95cbqu3RSWLhOR53_Cec47RQcoJEHpJySmlun9bKTOcdoT2HRFKd_IJOqKil50x_PvB3vkQHdd6TQhVWsln6JApbQQz6ghdfl3ilJMrG3y1WUOZIdWQE3ZpwDeu-iW6ggtMeYAY0gqHhKfgAcPtOlcY8JyxL5s6u9ieAdcQg3fP0dPRxQov7vYT9O3D-8vzT93Fl4-fz88uOt8TPnfUC5BKCC2kHkA445kBDpyD9NIMowLeeyCGaS4HIvzAJTPSC2O0Z9L1_AS92_mulx8TDB7SXFy06xKmFshmF-zDlxSu7CrfWElZrwVpBm_uDEr-uUCd7RSqhxhdgrxUS7UQPVFc6Ya-foRe56WkFm9L9UxoKugfauUi2JDG3P71W1N7JhQjgirBG3X6F6qtAVpxW4_H0O4fCF7tB_2d8L6PDVA7wJdca4HR-jC7uXWyOYdoKbHbibG7ibFtYux2YqxsSvpIeW_-Pw3baWpj0wrKXi3-KfoF7sjSJA |
CitedBy_id | crossref_primary_10_1177_2045894021996574 crossref_primary_10_3892_etm_2017_5160 crossref_primary_10_1371_journal_pone_0180724 crossref_primary_10_31089_1026_9428_2021_61_6_365_370 crossref_primary_10_1126_sciadv_adl4913 crossref_primary_10_1165_rcmb_2022_0056OC crossref_primary_10_1080_08958378_2024_2413373 crossref_primary_10_1186_s12931_019_1018_x crossref_primary_10_1007_s11596_019_2073_8 crossref_primary_10_7759_cureus_35425 crossref_primary_10_1007_s10787_022_01042_7 crossref_primary_10_1038_s41401_021_00693_6 crossref_primary_10_4081_monaldi_2023_2719 crossref_primary_10_1097_MD_0000000000009469 crossref_primary_10_1016_j_biopha_2017_08_126 crossref_primary_10_1093_rheumatology_keab118 crossref_primary_10_3390_ijms25147654 crossref_primary_10_1097_FJC_0000000000001156 crossref_primary_10_1186_s12931_018_0933_6 crossref_primary_10_1186_s12931_021_01832_7 crossref_primary_10_31089_1026_9428_2021_61_5_318_323 crossref_primary_10_1016_j_taap_2020_115242 crossref_primary_10_31089_1026_9428_2021_61_3_161_167 crossref_primary_10_1002_jbt_23071 crossref_primary_10_1016_j_jvc_2021_06_005 crossref_primary_10_3389_fneur_2024_1428625 crossref_primary_10_1016_j_taap_2020_115281 crossref_primary_10_1007_s11259_023_10106_0 crossref_primary_10_1016_j_taap_2022_116071 crossref_primary_10_1136_oemed_2021_108095 crossref_primary_10_1016_j_toxlet_2021_09_014 crossref_primary_10_1016_j_rmcr_2021_101522 crossref_primary_10_1016_j_ecoenv_2022_114100 crossref_primary_10_1186_s12989_020_00345_3 crossref_primary_10_1016_j_cbi_2023_110510 crossref_primary_10_1136_bmjopen_2023_078992 |
Cites_doi | 10.1016/j.healun.2012.11.014 10.1186/s12933-014-0119-6 10.1016/j.jvir.2010.02.030 10.1164/ajrccm.157.5.9707141 10.1093/aje/kwt139 10.1182/blood.V98.5.1456 10.1016/S0272-5231(05)70282-3 10.1097/00003246-199811000-00031 10.1007/BF02714139 10.1161/01.RES.87.5.418 10.1016/S0140-6736(95)90173-6 10.1183/09031936.01.00084601 10.1183/09031936.05.00072504 10.1182/blood.V97.6.1727 10.1378/chest.129.3.746 10.1126/science.1156995 10.1164/ajrccm.158.3.9709103 10.1002/ajim.20986 10.4049/jimmunol.157.3.1233 10.1183/13993003.00574-2015 10.1097/ACI.0b013e32802bf8a5 10.1016/j.ajpath.2013.01.010 10.1093/cvr/cvm102 10.1152/ajpheart.00254.2009 10.1023/A:1015967017103 10.1055/s-2004-831051 10.1136/oem.60.4.237 10.1164/ajrccm.164.9.2101036 10.1136/oem.58.1.31 10.1093/bmb/lds028 10.1152/jappl.1991.71.5.2012 |
ContentType | Journal Article |
Copyright | The Author(s). 2016 COPYRIGHT 2016 BioMed Central Ltd. Copyright BioMed Central 2016 |
Copyright_xml | – notice: The Author(s). 2016 – notice: COPYRIGHT 2016 BioMed Central Ltd. – notice: Copyright BioMed Central 2016 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7U7 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1186/s12931-016-0478-5 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1465-993X |
ExternalDocumentID | PMC5126840 4271136331 A472041743 27894297 10_1186_s12931_016_0478_5 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: National Institute on Alcohol Abuse and Alcoholism grantid: R01 AA019953 funderid: http://dx.doi.org/10.13039/100000027 – fundername: Research Incentive Grant from UofL School of Medicine – fundername: National Heart, Lung, and Blood Institute grantid: R56HL128597 funderid: http://dx.doi.org/10.13039/100000050 – fundername: BLRD VA grantid: I01 BX000216 – fundername: NHLBI NIH HHS grantid: R56 HL128597 – fundername: NIAAA NIH HHS grantid: R01 AA019953 – fundername: ; – fundername: ; grantid: R01 AA019953 – fundername: ; grantid: R56HL128597 |
GroupedDBID | --- 0R~ 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7QL 7U7 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c603t-1c4e57448458de4a9c29e3e33e5c59df7e36ce092835d04cd35295c4998c25a63 |
IEDL.DBID | M48 |
ISSN | 1465-993X 1465-9921 |
IngestDate | Thu Aug 21 13:55:13 EDT 2025 Fri Sep 05 04:22:27 EDT 2025 Thu Sep 18 13:10:47 EDT 2025 Tue Jun 17 22:05:45 EDT 2025 Tue Jun 10 21:05:09 EDT 2025 Thu Apr 03 07:03:42 EDT 2025 Tue Jul 01 02:43:09 EDT 2025 Thu Apr 24 23:08:47 EDT 2025 Sat Sep 06 07:29:01 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Vascular remodeling Animal model Silicosis Pulmonary hypertension |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c603t-1c4e57448458de4a9c29e3e33e5c59df7e36ce092835d04cd35295c4998c25a63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doi.org/10.1186/s12931-016-0478-5 |
PMID | 27894297 |
PQID | 1846248141 |
PQPubID | 42864 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5126840 proquest_miscellaneous_1844607378 proquest_journals_1846248141 gale_infotracmisc_A472041743 gale_infotracacademiconefile_A472041743 pubmed_primary_27894297 crossref_citationtrail_10_1186_s12931_016_0478_5 crossref_primary_10_1186_s12931_016_0478_5 springer_journals_10_1186_s12931_016_0478_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-11-28 |
PublicationDateYYYYMMDD | 2016-11-28 |
PublicationDate_xml | – month: 11 year: 2016 text: 2016-11-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Respiratory research |
PublicationTitleAbbrev | Respir Res |
PublicationTitleAlternate | Respir Res |
PublicationYear | 2016 |
Publisher | BioMed Central BioMed Central Ltd Nature Publishing Group |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Nature Publishing Group |
References | E Frisdal (478_CR27) 2001; 18 F Saboor (478_CR35) 2016; 47 A Seaton (478_CR10) 1995; 345 GS Davis (478_CR16) 1998; 17 J Wright (478_CR20) 1991; 169 R Jandova (478_CR13) 1980; 22 V Castranova (478_CR5) 2002; 234–235 A Nemmar (478_CR9) 2001; 164 J Schmeck (478_CR22) 1998; 26 E Hnizdo (478_CR1) 2003; 60 TJ McMahon (478_CR23) 1985; 71 Y Rival (478_CR31) 1996; 157 J Carlsen (478_CR14) 2013; 32 F Huaux (478_CR6) 2007; 7 S Honnons (478_CR17) 2000; 19 JM Hughes (478_CR4) 1998; 158 DD Landen (478_CR11) 2011; 54 C Dostert (478_CR7) 2008; 320 M Rabinovitch (478_CR29) 2001; 22 BT Mossman (478_CR8) 1998; 157 DP Hajjar (478_CR24) 2013; 182 K Tardif (478_CR34) 2014; 13 S Patil (478_CR33) 2001; 97 W Chen (478_CR18) 2001; 58 KL Jones (478_CR32) 2001; 98 R Rajkumar (478_CR36) 2010; 298 A Hyduk (478_CR12) 2005; 54 SN Hu (478_CR19) 1990; 114 A Vieillard-Baron (478_CR30) 2000; 87 CJ Lettieri (478_CR15) 2006; 129 S Misra (478_CR28) 2010; 21 H Lepetit (478_CR26) 2005; 25 PD McGavran (478_CR21) 1990; 136 P Cullinan (478_CR3) 2012; 104 VW van Hinsbergh (478_CR25) 2008; 78 A Bikfalvi (478_CR37) 2004; 30 Y Liu (478_CR2) 2013; 178 16280974 - MMWR Surveill Summ. 2005 Nov 11;54(5):1-28 15282661 - Semin Thromb Hemost. 2004 Jun;30(3):379-85 1849213 - Lung. 1991;169(1):31-42 11213022 - J Environ Pathol Toxicol Oncol. 2000;19(4):391-400 11757635 - Eur Respir J. 2001 Nov;18(5):838-45 18403674 - Science. 2008 May 2;320(5876):674-7 11590839 - Clin Chest Med. 2001 Sep;22(3):433-49, viii 21761428 - Am J Ind Med. 2011 Oct;54(10):727-33 9731009 - Am J Respir Crit Care Med. 1998 Sep;158(3):807-14 1837015 - J Appl Physiol (1985). 1991 Nov;71(5):2012-8 9546745 - J Environ Pathol Toxicol Oncol. 1998;17(2):81-97 23265910 - J Heart Lung Transplant. 2013 Mar;32(3):347-54 17351471 - Curr Opin Allergy Clin Immunol. 2007 Apr;7(2):168-73 16537877 - Chest. 2006 Mar;129(3):746-52 2156434 - Am J Pathol. 1990 Mar;136(3):695-705 9824081 - Crit Care Med. 1998 Nov;26(11):1868-74 11719307 - Am J Respir Crit Care Med. 2001 Nov 1;164(9):1665-8 10969041 - Circ Res. 2000 Sep 1;87(5):418-25 7741860 - Lancet. 1995 Jan 21;345(8943):176-8 12162431 - Mol Cell Biochem. 2002 May-Jun;234-235(1-2):177-84 25139503 - Cardiovasc Diabetol. 2014 Aug 21;13:119 8757631 - J Immunol. 1996 Aug 1;157(3):1233-41 2145819 - Arch Pathol Lab Med. 1990 Oct;114(10):1063-70 20081107 - Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1235-48 12660371 - Occup Environ Med. 2003 Apr;60(4):237-43 18079100 - Cardiovasc Res. 2008 May 1;78(2):203-12 9603153 - Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1666-80 24043436 - Am J Epidemiol. 2013 Nov 1;178(9):1424-33 20434368 - J Vasc Interv Radiol. 2010 Jun;21(6):896-902 11520795 - Blood. 2001 Sep 1;98(5):1456-63 23608224 - Am J Pathol. 2013 May;182(5):1474-81 15863640 - Eur Respir J. 2005 May;25(5):834-42 26699726 - Eur Respir J. 2016 Mar;47(3):876-88 23080418 - Br Med Bull. 2012;104:143-61 11119632 - Occup Environ Med. 2001 Jan;58(1):31-7 11238114 - Blood. 2001 Mar 15;97(6):1727-32 7449392 - Cor Vasa. 1980;22(4):221-37 |
References_xml | – volume: 32 start-page: 347 year: 2013 ident: 478_CR14 publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2012.11.014 – volume: 13 start-page: 119 year: 2014 ident: 478_CR34 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-014-0119-6 – volume: 21 start-page: 896 year: 2010 ident: 478_CR28 publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2010.02.030 – volume: 157 start-page: 1666 year: 1998 ident: 478_CR8 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.157.5.9707141 – volume: 54 start-page: 1 year: 2005 ident: 478_CR12 publication-title: MMWR Surveill Summ – volume: 178 start-page: 1424 year: 2013 ident: 478_CR2 publication-title: Am J Epidemiol doi: 10.1093/aje/kwt139 – volume: 98 start-page: 1456 year: 2001 ident: 478_CR32 publication-title: Blood doi: 10.1182/blood.V98.5.1456 – volume: 22 start-page: 433 year: 2001 ident: 478_CR29 publication-title: Clin Chest Med doi: 10.1016/S0272-5231(05)70282-3 – volume: 26 start-page: 1868 year: 1998 ident: 478_CR22 publication-title: Crit Care Med doi: 10.1097/00003246-199811000-00031 – volume: 169 start-page: 31 year: 1991 ident: 478_CR20 publication-title: Lung doi: 10.1007/BF02714139 – volume: 87 start-page: 418 year: 2000 ident: 478_CR30 publication-title: Circ Res doi: 10.1161/01.RES.87.5.418 – volume: 345 start-page: 176 year: 1995 ident: 478_CR10 publication-title: Lancet doi: 10.1016/S0140-6736(95)90173-6 – volume: 18 start-page: 838 year: 2001 ident: 478_CR27 publication-title: Eur Respir J doi: 10.1183/09031936.01.00084601 – volume: 19 start-page: 391 year: 2000 ident: 478_CR17 publication-title: J Environ Pathol Toxicol Oncol – volume: 25 start-page: 834 year: 2005 ident: 478_CR26 publication-title: Eur Respir J doi: 10.1183/09031936.05.00072504 – volume: 97 start-page: 1727 year: 2001 ident: 478_CR33 publication-title: Blood doi: 10.1182/blood.V97.6.1727 – volume: 136 start-page: 695 year: 1990 ident: 478_CR21 publication-title: Am J Pathol – volume: 129 start-page: 746 year: 2006 ident: 478_CR15 publication-title: Chest doi: 10.1378/chest.129.3.746 – volume: 320 start-page: 674 year: 2008 ident: 478_CR7 publication-title: Science doi: 10.1126/science.1156995 – volume: 158 start-page: 807 year: 1998 ident: 478_CR4 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.158.3.9709103 – volume: 54 start-page: 727 year: 2011 ident: 478_CR11 publication-title: Am J Ind Med doi: 10.1002/ajim.20986 – volume: 157 start-page: 1233 year: 1996 ident: 478_CR31 publication-title: J Immunol doi: 10.4049/jimmunol.157.3.1233 – volume: 47 start-page: 876 year: 2016 ident: 478_CR35 publication-title: Eur Respir J doi: 10.1183/13993003.00574-2015 – volume: 7 start-page: 168 year: 2007 ident: 478_CR6 publication-title: Curr Opin Allergy Clin Immunol doi: 10.1097/ACI.0b013e32802bf8a5 – volume: 182 start-page: 1474 year: 2013 ident: 478_CR24 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2013.01.010 – volume: 22 start-page: 221 year: 1980 ident: 478_CR13 publication-title: Cor Vasa – volume: 78 start-page: 203 year: 2008 ident: 478_CR25 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvm102 – volume: 114 start-page: 1063 year: 1990 ident: 478_CR19 publication-title: Arch Pathol Lab Med – volume: 298 start-page: H1235 year: 2010 ident: 478_CR36 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00254.2009 – volume: 17 start-page: 81 year: 1998 ident: 478_CR16 publication-title: J Environ Pathol Toxicol Oncol – volume: 234–235 start-page: 177 year: 2002 ident: 478_CR5 publication-title: Mol Cell Biochem doi: 10.1023/A:1015967017103 – volume: 30 start-page: 379 year: 2004 ident: 478_CR37 publication-title: Semin Thromb Hemost doi: 10.1055/s-2004-831051 – volume: 60 start-page: 237 year: 2003 ident: 478_CR1 publication-title: Occup Environ Med doi: 10.1136/oem.60.4.237 – volume: 164 start-page: 1665 year: 2001 ident: 478_CR9 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.164.9.2101036 – volume: 58 start-page: 31 year: 2001 ident: 478_CR18 publication-title: Occup Environ Med doi: 10.1136/oem.58.1.31 – volume: 104 start-page: 143 year: 2012 ident: 478_CR3 publication-title: Br Med Bull doi: 10.1093/bmb/lds028 – volume: 71 start-page: 2012 year: 1985 ident: 478_CR23 publication-title: J Appl Physiol doi: 10.1152/jappl.1991.71.5.2012 – reference: 18079100 - Cardiovasc Res. 2008 May 1;78(2):203-12 – reference: 11520795 - Blood. 2001 Sep 1;98(5):1456-63 – reference: 1837015 - J Appl Physiol (1985). 1991 Nov;71(5):2012-8 – reference: 24043436 - Am J Epidemiol. 2013 Nov 1;178(9):1424-33 – reference: 2145819 - Arch Pathol Lab Med. 1990 Oct;114(10):1063-70 – reference: 1849213 - Lung. 1991;169(1):31-42 – reference: 9546745 - J Environ Pathol Toxicol Oncol. 1998;17(2):81-97 – reference: 7449392 - Cor Vasa. 1980;22(4):221-37 – reference: 2156434 - Am J Pathol. 1990 Mar;136(3):695-705 – reference: 23265910 - J Heart Lung Transplant. 2013 Mar;32(3):347-54 – reference: 11238114 - Blood. 2001 Mar 15;97(6):1727-32 – reference: 9603153 - Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1666-80 – reference: 9731009 - Am J Respir Crit Care Med. 1998 Sep;158(3):807-14 – reference: 21761428 - Am J Ind Med. 2011 Oct;54(10):727-33 – reference: 12162431 - Mol Cell Biochem. 2002 May-Jun;234-235(1-2):177-84 – reference: 17351471 - Curr Opin Allergy Clin Immunol. 2007 Apr;7(2):168-73 – reference: 20434368 - J Vasc Interv Radiol. 2010 Jun;21(6):896-902 – reference: 16537877 - Chest. 2006 Mar;129(3):746-52 – reference: 15282661 - Semin Thromb Hemost. 2004 Jun;30(3):379-85 – reference: 23080418 - Br Med Bull. 2012;104:143-61 – reference: 10969041 - Circ Res. 2000 Sep 1;87(5):418-25 – reference: 15863640 - Eur Respir J. 2005 May;25(5):834-42 – reference: 11590839 - Clin Chest Med. 2001 Sep;22(3):433-49, viii – reference: 25139503 - Cardiovasc Diabetol. 2014 Aug 21;13:119 – reference: 20081107 - Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1235-48 – reference: 8757631 - J Immunol. 1996 Aug 1;157(3):1233-41 – reference: 18403674 - Science. 2008 May 2;320(5876):674-7 – reference: 26699726 - Eur Respir J. 2016 Mar;47(3):876-88 – reference: 11719307 - Am J Respir Crit Care Med. 2001 Nov 1;164(9):1665-8 – reference: 9824081 - Crit Care Med. 1998 Nov;26(11):1868-74 – reference: 11213022 - J Environ Pathol Toxicol Oncol. 2000;19(4):391-400 – reference: 23608224 - Am J Pathol. 2013 May;182(5):1474-81 – reference: 12660371 - Occup Environ Med. 2003 Apr;60(4):237-43 – reference: 7741860 - Lancet. 1995 Jan 21;345(8943):176-8 – reference: 11757635 - Eur Respir J. 2001 Nov;18(5):838-45 – reference: 11119632 - Occup Environ Med. 2001 Jan;58(1):31-7 – reference: 16280974 - MMWR Surveill Summ. 2005 Nov 11;54(5):1-28 |
SSID | ssj0017875 |
Score | 2.3681867 |
Snippet | Background
Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and... Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and progressive... Background Occupational and environmental exposure to crystalline silica may lead to the development of silicosis, which is characterized by inflammation and... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 160 |
SubjectTerms | Animal models Animals Collagen - metabolism Development and progression Extracellular Matrix Proteins - metabolism Gene Expression Regulation - drug effects Hemodynamics - drug effects Histology Histopathology Hypertension Hypertension, Pulmonary - chemically induced Hypertension, Pulmonary - pathology Hypertrophy, Right Ventricular - chemically induced Hypertrophy, Right Ventricular - pathology Inflammation - chemically induced Inflammation - pathology Injections, Spinal Lung - pathology Male Medicine Medicine & Public Health Mice Mice, Inbred C57BL Muscle, Smooth, Vascular - drug effects Muscle, Smooth, Vascular - pathology Physiological aspects Pneumology/Respiratory System Pulmonary Fibrosis - chemically induced Pulmonary Fibrosis - complications Pulmonary Fibrosis - pathology Pulmonary hypertension Risk factors Silica Silicon Dioxide - toxicity Silicosis Silicosis - pathology Vascular Remodeling - drug effects |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0gvgifptaZQVBUEKT7EeyT1LEUoSKDy3cW0gmE3pQkjO5A_vfdybZxObAPu8k2czOzsxvZ3ZGiE8OXVEUtQ6dslmotYOwTFCFSV1GkNUIsePLyee_7Nml_rkyK3_g1vu0ykknDoq6aoHPyI8JidhEZ7GOv23-hNw1iqOrvoXGQ_EoJk-EWzekqxlwxSSMZrxdZELnkthHNePMHvds5xhIE57WBKTMwi7ta-c75mk_dXIvfjqYpdNn4qn3J-XJKADPxQNsXojH5z5i_lJc_N5d09SL7kZeEeTshoT1tpFFU8kpC1V2ODTEoQ_IdSO5Qb3Ev5u2x0puWwndDbmQXLsbZb_mQ75X4vL0x8X3s9B3UgjBRmobxqDRpITEtMkq1IWDxKFCpdCAcVWdorKAkePia1WkoVIc_wNCQxkkprDqtTho2gbfCknwJMMEFJDroesyKbG0QF4PYqRqUC4Q0cTHHHyZce52cZ0PcCOz-cj6nFPLmPW5CcSX-ZHNWGPjPuLPvDg57z96LxT-GgHNjitZ5Sea2-4wzgrE0YKS9g0sh6flzf2-7fN_UhaIj_MwP8m5aA22u4FGW9KMaRaIN6M0zNPme8Vk4dNApAs5mQm4mvdypFlfDVW9yfPiwjuB-DpJ1J1p_Y8bh_f_xDvxJGERj-MwyY7Ewbbb4Xtyorblh2Gn3AImlxgx priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9RADA96gvgifls9ZQRBUIpt56Mzj8ficQgnPtzBvZU2TbmFoz26u-D99ybdbtkuKvg8me4wk5nkt0l-AfgYKJRl2Zg4aOdjYwLGVUY6zpoqQd8QpkGKk89_uLNL8_3KXo1k0VILsx-_T737uhJ7JICXca9hwGPvwwPL764o88ItpoAB650dg5Z_nDYzO4eP7571OcyMPAiPDlbn9Ak8Ht1FdbI936dwj9pn8PB8DIg_h4ufmxtWpLK_U9eMKPshH71rVdnWapdkqnoa-t3wD6hlq6T_vKJft92KarXuFPZ37CEKNTep1VL-w3sBl6ffLhZn8dgoIUaX6HWcoiGbM9Ay1tdkyoBZIE1ak0Ub6iYn7ZCSINxqdWKw1hLeQwY7HjNbOv0SjtqupdegGH14ylAjexamqbKKKofs1BAlukEdIkh2-1jgyCIuzSxuigFNeFdst76QzDHZ-sJG8Hmacrul0PiX8Cc5nEKuF38Xy7FKgFcnRFXFiZGuOgKjIjieSfK1wPnw7niL8VquCoazLjM-NWkEH6ZhmSmpZi11m0HGOH74ch_Bq602TMuWsmE24HkE-UxPJgEh656PtMvrgbSbHSvh1Yngy06j9pb1t91481_Sb-FRJhqfpnHmj-Fo3W_oHbtM6-r9cFl-AxU5DtU priority: 102 providerName: Springer Nature |
Title | Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica |
URI | https://link.springer.com/article/10.1186/s12931-016-0478-5 https://www.ncbi.nlm.nih.gov/pubmed/27894297 https://www.proquest.com/docview/1846248141 https://www.proquest.com/docview/1844607378 https://pubmed.ncbi.nlm.nih.gov/PMC5126840 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_6AWMvY9_z2gUNBoMNb7Yly_bDGFloKYGWsjWQN2PLZxoIduck0Pz3vZPtrAndYE8GS7bF6Sff_XSnO4APCSZZlpXKTaSOXaUS4-YBSjcoc8_EJRo_4cPJ5xf6bKLG03C6B315q06AiwepHdeTmjTzL7e_199pwX-zCz7WXxess5gUEzdWRIrCfTi07iKO5FN_nAqEzbA9bBS6pJannZPzwVdsqandn_U9bbUbSbnjTrVa6vQpPOnMSzFs8fAM9rB6Do_OOwf6C7i6XM0JeFmzFtfEQBsbv15XIqsK0QeligZtfRz6gJhVguvVC7y9qRdYiGUtTLMmi5JTeaNYzHjP7yVMTk-uRmduV1jBNdqTS9c3CsOIiJkK4wJVlpggQYlSYmjCpCgjlNqgl3AutsJTppDsDjREjmIThJmWr-Cgqit8A4LYSoyBkYYsEVXmQY65NmQEIXqyNDJxwOvlmJou6zgXv5inln3EOm1Fn3KkGYs-DR34tHnkpk258a_OH3lyUgYIvddk3akCGh0ntkqHiqvwMO1y4HirJy0js93cT2_aozAl-qsDFfvKd-D9ppmf5NC0CuuV7aM0_Sij2IHXLRo2w-ZjxqTwIweiLZxsOnBy7-2WanZtk3yTIcZ5eBz43CPq3rD-Jo23_yO6I3gcMOB93w3iYzhYNit8RxbWMh_AfjSNBnA4HI5_jen64-Ti8ifdHenRwO5aDOzKugMOcCTX |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN9kDDASCAkULbGdNH6Y0IBNHVurCXXS3rLEuWiVRtI1raD_HH8bd2lS1krsbc92Eud8vruf7wvgnUGTJEmuXaPCyNXaWDeVqFyZp56NcrS-4eTk_iDsnervZ8HZBvxpc2E4rLKVibWgzkrLd-Q7hERCqSNf-5_HVy53jWLvattCI2laK2S7dYmxJrHjCOe_CMJVu4ffaL_fS3mwP_zac5suA64NPTV1fasx6BJK0UGUoU6MlQYVKoWBDUyWd1GFFj3DhckyT9tMsW_MElKIrAySUNF778Cm5guUDmx-2R-c_Fj6Meg4BIv8psA1RvqNX9WPwp2KNS1DeUL0mqBcsKIZ1_XDNQW5Hry55sGtFePBQ3jQWLRib8GCj2ADi8dwt9_47J_A8GR2ScRLJnNxQaB3UofMl4VIiky0cbBignVLHvqAGBXiJ0kvgb_HZYWZmJbCTuZkxHL1cBTViK8Zn8LprVD5GXSKssAXIAggRSitsmT86DyVKaahJbsL0VO5VcYBr6VjbJtC59xv4zKuAU8UxgvSxxzcxqSPAwc-Lh8ZL6p83DT5A29OzBKA3muTJpGBVse1tOI9zY1_GOk5sL0yk06uXR1utzduJEcV_-NzB94uh_lJjoYrsJzVc3RIsrkbOfB8wQ3LZXNmM9kYXQe6K3yynMD1xFdHitFFXVecbD8u_ePAp5ajri3rf9TYuvkn3sC93rB_HB8fDo5ewn3J7O77roy2oTOdzPAVmXTT9HVzbgSc3_ZR_QuSRlqT |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF-0heKL-N1o1RUEQQlNsh_ZfTzUo562FGyhbyHZTOhBSY4kB_a_dyZfNIcKPu9ssuzOZOaXmf0NY-8t2DRNC-lboY0vpXV-FoHwoyILnCnAhZYuJ5-e6ZNLubpSV0Of02asdh9Tkv2dBmJpKtvjTV70Jm70cUNeimAwomGJMEjdZ_tGWYvoa3-xWP1cTYkE1Ec1JDP_OHHmjnY_yne80m7F5E7atPNGy0fs4RBG8kV_7o_ZPSifsIPTIVH-lF2cb29QwdL6ll8j0qy7OvWq5GmZ87H4lNfQ9cHBF_B1yakvPYdfm6qBnLcVd_UtRo5E2Q28WdO_vWfscvn14vOJPzRQ8J0OROuHToKKEYBJZXKQqXWRBQFCgHLK5kUMQjsILHGu5YF0uaC0n0MQZFykUi2es72yKuGQcUQlBiInHEYcssiiDDLtMNgBCEThhPVYMO5j4gZ2cWpycZN0KMPopN_6hCrKaOsT5bGP05RNT63xL-EPdDgJmR0-16XD7QFcHRFYJQtJ3XYIXnnsaCaJ5uLmw-PxJoO5NgnCXB1JE8rQY--mYZpJJWglVNtORmr8IMbGYy96bZiWTdeJ0bHHHotnejIJEIn3fKRcX3dk3hhwEd-Oxz6NGnVnWX_bjZf_Jf2WHZx_WSY_vp19f8UeRKT8YehH5ojttfUWXmNU1WZvBsv5DRC6G4I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulmonary+hypertension+and+vascular+remodeling+in+mice+exposed+to+crystalline+silica&rft.jtitle=Respiratory+research&rft.au=Zelko%2C+Igor+N.&rft.au=Zhu%2C+Jianxin&rft.au=Ritzenthaler%2C+Jeffrey+D.&rft.au=Roman%2C+Jesse&rft.date=2016-11-28&rft.issn=1465-993X&rft.eissn=1465-993X&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-016-0478-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12931_016_0478_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon |